Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients

Journal of Diabetes and its Complications

Volumn 27, Issue 1, 2013, Pages 59-63

  Overgaard, Anne Julie ^a   McGuire, James N ^b   Hovind, Peter ^a   Parving, Hans Henrik ^c,d   Rossing, Peter ^e   Pociot, Flemming ^a,f  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e STENO DIABETES CENTER   (Denmark)

^f LUND UNIVERSITY   (Sweden)

Author keywords

Biomarkers; Diabetic nephropathy; Inflammation; Luminex technology

Indexed keywords

ADIPONECTIN; ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; FIBRONECTIN; SERUM AMYLOID A;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URINARY EXCRETION;

ADOLESCENT; ADULT; AGE OF ONSET; ALBUMINURIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; SERUM AMYLOID A PROTEIN; YOUNG ADULT;

EID: 84872492674     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.06.016     Document Type: Article

References (39)

1. S.-I. Araki, and D. Koya APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes Diabetes Care 26 8 2003 2416 2420
2. S. Araki, and D.K. Moczulski APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies Diabetes 49 12 2000 2190 2195
3. A.S. Astrup, and L. Tarnow Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years Diabetes Care 31 6 2008 1170 1176
4. S. Basu, and A. Larsson Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation Diabetes Care 28 6 2005 1371 1375
5. M. Dalla Vestra, and M. Mussap Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes Journal of the American Society of Nephrology 16 3-suppl-1 2005 S78 S82
6. T.W. Du Clos Function of C-reactive protein Annals of Medicine 32 4 2000 274 278
7. M. Eto, and K. Horita Increased frequency of apolipoprotein ε2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy Clinical Genetics 48 6 1995 288 292
8. Ferreira, I. (2008). EASD.
9. J. Frystyk, and L. Tarnow Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications Diabetologia 48 9 2005 1911 1918
10. S. Giunti, and D. Barit Mechanisms of diabetic nephropathy: role of hypertension Hypertension 48 4 2006 519 526
11. W. Gu, and L.X. Zou Analysis of urinary proteomic patterns for diabetic nephropathy by ProteinChip Proteom Clin APPL 2 2008 744 750
12. T.K. Hansen, and C. Forsblom Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes Diabetologia 53 2010 1517 1524
13. H.G. Hansen, and J. Overgaard Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis Proteomics Clin Appl 4 2010 697 705
14. P. Hovind, and L. Tarnow Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes Diabets Care 26 2003 1258 1264
15. P. Hovind, and L. Tarnow Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study BMJ 328 7448 2004 1105
16. H. Kimura, and Y. Suzuki Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM American Journal of Kidney Diseases 31 4 1998 666 673
17. R. Kisilevsky, and L. Subrahmanyan Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function Laboratory Investigation 66 6 1992 778 785
18. Y. Kumon, and T. Suehiro Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus Clinical Biochemistry 27 6 1994 469 473
19. A.S. Levey, and J.P. Bosch A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Annals of Internal Medicine 130 6 1999 461 470
20. J. Lin, and R.J. Glynn Inflammation and progressive nephropathy in type 1 diabetes in the Diabetes Control and Complications Trial Diabetes Care 31 12 2008 2338 2343
21. A. Mackiewicz, and M.K. Ganapathi Transforming growth factor beta 1 regulates production of acute-phase proteins Proceedings of the National Academy of Sciences of the United States of America 87 4 1990 1491 1495
22. T. Onuma, and L.M. Laffel Apolipoprotein E genotypes and risk of diabetic nephropathy Journal of the American Society of Nephrology 7 7 1996 1075 1078
23. H.H. Otu, and H. Can Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy Diabetes Care 30 3 2007 638 643
24. A. Overgaard, and H. Hansen Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy Proteome Science 8 1 2010 4
25. A. Overgaard, and T. Thingholm Quantitative iTRAQ-based proteomic identification of candidate biomarkers for diabetic nephropathy in plasma of type 1 diabetic patients Clinical Proteomics 6 4 2010 105 114
26. P.V. Rao, and X. Lu Proteomic identification of urinary biomarkers of diabetic nephropathy Diabetes Care 30 3 2007 629 637
27. K. Rossing, and H. Mischak Urinary proteomics in diabetes and CKD Journal of the American Society of Nephrology 19 7 2008 1283 1290
28. P. Rossing, and P. Hougaard Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients Diabetes Care 25 5 2002 859 864
29. J.C. Rutledge, and K.F. Ng Role of triglyceride-rich lipoproteins in diabetic nephropathy Nature Reviews Nephrology 6 6 2010 361 370
30. M. Saraheimo, and C. Forsblom Serum adiponectin is increased in type 1 diabetic patients with nephropathy Diabetes Care 28 6 2005 1410 1414
31. M. Saraheimo, and A.M. Teppo Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients Diabetologia 46 10 2003 1402 1407
32. T. Shoji, and E. Ishimura Atherogenic lipoproteins in end-stage renal disease American Journal of Kidney Diseases 38 4, Supplement 1 2001 S30 S33
33. C.D.A. Stehouwer, and M.-A. Gall Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes Diabetes 51 4 2002 1157 1165
34. C. Tape, and R. Kisilevsky Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1043 3 1990 295 300
35. G. Targher, and L. Bertolini Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy Diabetic Medicine 22 8 2005 999 1004
36. N. Tolonen, and C. Forsblom Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes Diabetologia 52 12 2009 2522 2530
37. N. Tolonen, and C. Forsblom Relationship between lipid profiles and kidney function in patients with type 1 diabetes Diabetologia 51 1 2008 12 20
38. E. Werle, and W. Fiehn Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients Diabetes Care 21 6 1998 994 998
39. T. Yamamoto, and T. Nakamura Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy Proceedings of the National Academy of Sciences of the United States of America 90 5 1993 1814 1818